CDC Issues Alert on Omicron Variant, Provides HCP Recommendations
The CDC is recommending that health care providers take a travel history for all suspected and confirmed cases of COVID-19.
COVID19
CDC to Toughen COVID-19 Testing for International Travelers
Not clear whether the new, tougher rule will require an antigen or rapid PCR test
FDA Panel Votes in Favor of COVID-19 Pill But With Concerns
Molnupiravir is an orally administered form of a ribonucleoside analogue that inhibits the replication of SARS-CoV-2.
Colchicine No Benefit Over Supportive Care for COVID-19
No significant reduction reported in mortality, ventilatory support, ICU admission, length of stay, serious adverse events; increase seen in adverse events, diarrhea
Additional Data Support Efficacy of Molnupiravir for Mild to Moderate COVID-19
The phase 3 MOVe-OUT trial included all 1433 at risk adults with mild to moderate COVID-19 and symptom onset within 5 days of randomization.
Moderna to Test COVID-19 Booster Candidates Against Omicron Variant
A new booster candidate specific for Omicron is also being planned.
Pandemic Had Greater Effect on Work-Life Balance for Female Physicians
A sizable gender gap evident for risk of depression and anxiety
Risk for Stillbirth Elevated for Deliveries With COVID-19
Adjusted relative risk for stillbirth higher in deliveries with COVID-19 in pre-delta and delta periods, with stronger link during delta period
Thirty Percent of Hospital-Based Health Care Personnel Unvaccinated
COVID-19 vaccination coverage increased from 36.1 to 60.2 percent from January to April 2021, then slowed, reaching 70.0 percent as of Sept. 15
Longer-Term Data: Pfizer-BioNTech COVID-19 Vaccine Highly Effective in Adolescents
Findings from data collected between November 2020 and September 2021 showed that among 2228 participants, the vaccine was 100% effective.
